feed,title,long_url,short_url
Motley,What Investors Can Learn From Biogen's Drug Approval That No One Wants,https://www.fool.com/investing/2022/02/23/what-investors-can-learn-from-biogens-drug-approva/?source=iedfolrf0000001,https://bit.ly/3hdcaU8
